Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation

Immunotherapeutics include drugs and biologics that render therapeutic benefit by harnessing the power of the immune system. The promise of immune-mediated therapies is target specificity with a consequent reduction in off-target side effects. Recent scientific advances have led to clinical trials o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatsan, Ramjay S, Bross, Peter F, Liu, Ke, Theoret, Marc, De Claro, Angelo R, Lu, Jinhua, Helms, Whitney, Niland, Brian, Husain, Syed R, Puri, Raj K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986979/
https://www.ncbi.nlm.nih.gov/pubmed/24764535
http://dx.doi.org/10.1186/2051-1426-1-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986979/
https://www.ncbi.nlm.nih.gov/pubmed/24764535
http://dx.doi.org/10.1186/2051-1426-1-5

Ejemplares similares